
Supply
30 Days
Format
Liquid liposomal
Serving
10 ml daily
Human RCT Proven
Made in Germany
EFSA Bone Claim
LSO-MG
5.18× OBV vs. standard tablet · liposomal magnesium bisglycinate
LipoSone™ Liposomal Magnesium — 5.18 times higher bioavailability than standard non-liposomal tablet magnesium in a human RCT (n=20). Sustained elevated plasma magnesium levels for the full 12-hour study window. Magnesium contributes to the maintenance of normal bones. Made in Germany.
or €35.70/mo with Subscribe & Save 15%
Join our newsletter to be notified when stock is replenished.
Free EU shipping · 30-day guarantee · Secure checkout
Human RCT Proven
Made in Germany
EFSA Bone Claim
GMP Certified
Your 90-Day Protocol
Day 1
Commit to the protocol: same time, same dose, every day. Consistency is the active ingredient no formula can substitute.
Week 1
Seven days in. The most important work happening now is behavioural — you're cementing the routine that makes supplementation work.
Day 14
Most nutritional actives are studied across 4–12 week windows. At two weeks your protocol is running — not complete.
Day 30
A full month of consistent intake. If you've been tracking anything — energy, sleep, mood — now is a useful moment to note what, if anything, has shifted. Individual results vary.
Day 60–90
At 60–90 days you're running the timeline most nutritional supplement research is built around. This is where meaningful individual differences emerge.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.
Questions
Science
Four precision-sequenced biological events that distinguish this formulation from commodity supplements.
Step 01
Magnesium bisglycinate encased in phospholipid liposomes, protecting it through digestion
Step 02
Liposomal delivery bypasses degradation pathways that limit standard tablet uptake
Step 03
Plasma magnesium stayed above the 0.85–1.10 nmol/L reference range for the full study window
Step 04
Magnesium contributes to the maintenance of normal bones
Formula
Clinical dosages. No proprietary blends. Complete transparency on every active.
| Ingredient | Origin | Clinical Dose | Primary Function | Delivery |
|---|---|---|---|---|
Magnesium (as bisglycinate, liposomal) Magnesium Bisglycinate [] | 100mg/10mL | Contributes to the maintenance of normal bones | 5.18× OBV vs. standard non-liposomal tablet (RCT n=20) |
Transparency
Verified supply chain documentation — not marketing copy.
Evidence
EFSA-registered health claims and peer-reviewed supporting literature. Every [n] in this page links here.
“”
EFSA Journal 2009;7(9):1216, doi:10.2903/j.efsa.2009.1216